Latest updates for Cell Therapy

Fresh curated links around Cell therapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Where Next For Present Stem Cell Therapies?
  • Creation of Chimeric Antigen Receptor Natural Killer Cells in Situ via Messenger RNA Therapy
  • Stanford blood cancer transplant therapy reaches first commercial patient

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fightaging.org /3 weeks ago

Where Next For Present Stem Cell Therapies?

First generation stem cell therapies have become widespread; they are readily accessed in medical tourism clinics, and are also available for a range of issues in more regulated pa...

Read source
fightaging.org /4 days ago

Creation of Chimeric Antigen Receptor Natural Killer Cells in Situ via Messenger RNA Therapy

Messenger RNA (mRNA) can be delivered into tissues and cells by encapsulating it into lipid nanoparticles (LNPs), and then injecting the nanoparticles. A target cell engulfs a LNP,...

Read source
timesofindia.indiatimes.com /2 weeks ago

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Read source
multiple-sclerosis-research.org /3 weeks ago

CAR-T cell therapy

In this study the people had been treated with anti-CD20 antibodies and they had no cells when treatment was started and they B cells began to recover by 12 weeks and back to norma...

Read source
genengnews.com /1 month ago

Notch Signaling Switch Enables Scalable Helper T Cell Production for CAR T

By modulating Notch and T cell receptor signaling, scientists have produced functional CD4+ T cells from iPSCs, potentially advancing scalable, off-the-shelf CAR T therapies. The p...

Read source
genengnews.com /1 month ago

Advancing Cell Therapy for Cardiovascular Disease

In this GEN webinar, our expert speaker Joshua Michael Hare, MD, will examine how therapeutically relevant research is helping shape the development of cell therapies for cardiovas...

Read source
fightaging.org /3 weeks ago

Possible Approaches to Engineering Better Therapeutic Delivery of Mitochondria

Mitochondrial transplantation as a form of therapy to improve mitochondrial function in aged tissues has barely started as a going concern, and only a few patients have been treate...

Read source
bioengineer.org /2 weeks ago

Stem Cell Feeder Platforms Boost Natural Killer Cells for Cancer Immunotherapy

Researchers have developed engineered feeder cells derived from induced pluripotent stem cells that prolong the survival and boost the killing power of natural killer cells, offeri...

Read source
fightaging.org /5 days ago

Life Biosciences Reports Initial Results from the First Reprogramming Trial

Partial epigenetic reprogramming involves exposing cells to some or all of the Yamanaka factors for a long enough period of time to reset epigenetic decorations on nuclear DNA and...

Read source
multiple-sclerosis-research.org /1 month ago

CAR-T Made easy

Chimeric antigen receptor (CAR) therapy is away you harness the specificity potential of antibodies and the killing potential of T cells. You make T cells to express bits of an ant...

Read source
bioengineer.org /2 weeks ago

Lipid Nanoparticles Deliver CAR Instructions to T Cells Without Viruses

Researchers have engineered a custom ionizable lipid nanoparticle that delivers CAR-encoding mRNA into human T cells with over 90 percent efficiency, producing potent antitumor act...

Read source
scitechdaily.com /1 month ago

UCLA Scientists Develop Cancer-Fighting Cells That Tumors Struggle to Escape

UCLA scientists engineered ready-made T cells from cord blood stem cells that can hunt solid tumors even when cancer cells hide their main target. T cell receptor therapy, commonly...

Read source
scitechdaily.com /1 day ago

MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer

Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune di...

Read source
singularityhub.com /1 month ago

Single CAR T Injection Eases Multiple Sclerosis Symptoms in Small Trial

A potentially safer, simpler way to create CAR T cells in the body could bring this powerful therapy to the masses. The post Single CAR T Injection Eases Multiple Sclerosis Symptom...

Read source
genengnews.com /1 week ago

Cell Therapy Manufacturing Takes Shape Across Asia-Pacific

Cell and gene therapy is accelerating across Asia-Pacific, but manufacturing remains fragmented. Strategic automation, adaptable bioprocessing platforms, stronger supply chains, an...

Read source
kevinmd.com /1 month ago

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

Read source
fightaging.org /1 week ago

Dental Pulp Stem Cell Secretome as a Treatment to Improve Outcomes Following Stroke

Since stem cell therapies produce beneficial effects via a short burst of signaling from the transplanted cells rather than via any long-lasting survival and engraftment of those c...

Read source
gizmodo.com /4 weeks ago

Living Drugs Transformed Blood Cancer Treatment—and That’s Just the Beginning

Renier Brentjen, an early pioneer of CAR T cell therapy, is working on the next generation of these living drugs that can hopefully treat solid tumors, too.

Read source
thetruckersreport.com /3 weeks ago

Stem Cell Therapy

Read source
genengnews.com /1 month ago

No One-Size-Fits-All Solution for Autologous Cell Therapy Manufacturing

The operational challenges of making patient-specific cell therapies require careful consideration. Choosing the manufacturing model that fits the healthcare infrastructure, the lo...

Read source
asiatimes.com /1 month ago

Cheaper CAR-T therapy drawing global cancer patients to China

At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to US$600,000 for CAR-T therapy. He paid less than half t...

Read source
genengnews.com /1 month ago

CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial

Researchers at Charité report promising results from the first CAR T-cell trial for treatment-refractory rheumatoid arthritis, with all six patients improving and three achieving s...

Read source
singularityhub.com /1 month ago

Three-Year-Old Boy’s Metastatic Cancer Disappears After Two Shots of Experimental Cell Therapy

The boy, whose liver cancer had spread to his lungs, suffered no dangerous side effects and remained cancer-free a year later. The post Three-Year-Old Boy’s Metastatic Cancer Disap...

Read source
fightaging.org /1 week ago

A Review of Animal Study Evidence for Mesenchymal Stem Cell Therapy to Treat Neurodegeneration

Researchers here assess the present animal study evidence for first generation stem cell therapies to produce benefits in the most common neurodegenerative conditions, and also the...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Cell Therapy

feeds.feedburner.com

Recent coverage from public sources
Public source

asiatimes.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

gizmodo.com

Recent coverage from public sources
Public source